Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia
Zhen Tian, Xiaoyu Wei, Srinivas Chatla, Yang Liu et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Elliot Stieglitz
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
239Publications signalées
2415Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Publications récentes
HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL
Kevin O. McNerney, Soyang Kwon, Swati Naik, Vanessa A. Fabrizio et autres
0 citationsBlood Advances
Supplementary Figure S1 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Figure S6 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Table S5 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Table S2 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Figure S5 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Figure S7 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Table S4 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Table S7 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Figure S2 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
Supplementary Table S3 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Elliot Stieglitz, Alex G. Lee, Steven P. Angus, Christopher Davis et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.